Скачать или смотреть Boosting CGT Manufacturing 🔬 🦠

🎥 SPOTLIGHT CLIP: The burgeoning field of 𝐂𝐞𝐥𝐥 𝐚𝐧𝐝 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 (CGT) has often been called “𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞,” with massive clinical potential. 💉 💊 However, the industry has faced a variety of challenges, from awareness and funding to obstacles in CGT #manufacturing processes.

We’re spotlighting 𝗔𝘂𝘁𝗼𝗹𝗼𝗺𝗼𝘂𝘀 and its software program, 𝗔𝘂𝘁𝗼𝗹𝗼𝗠𝗔𝗧𝗘®, which helps CGT manufacturers integrate information, scale, and streamline operations to lower costs. The #technology provides support from development and clinical trials, toward commercialization. The goal is to expand the reach of 𝐂𝐆𝐓 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 to more patients. ⚕️ 🌎

“𝘼𝙪𝙩𝙤𝙡𝙤𝙈𝘼𝙏𝙀® 𝙚𝙣𝙖𝙗𝙡𝙚𝙨 𝙩𝙝𝙚 𝙨𝙝𝙖𝙧𝙞𝙣𝙜 𝙤𝙛 𝙞𝙣𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙨𝙩𝙖𝙣𝙙𝙖𝙧𝙙𝙞𝙯𝙚 𝙥𝙧𝙤𝙘𝙚𝙨𝙨𝙚𝙨. 𝙒𝙚 𝙘𝙖𝙣 𝙩𝙚𝙡𝙡 𝙬𝙝𝙖𝙩’𝙨 𝙝𝙖𝙥𝙥𝙚𝙣𝙞𝙣𝙜 𝙞𝙣 𝙧𝙚𝙖𝙡 𝙩𝙞𝙢𝙚 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙥𝙧𝙤𝙙𝙪𝙘𝙩𝙞𝙤𝙣 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨, 𝙖𝙨 𝙬𝙚𝙡𝙡 𝙖𝙨 𝙥𝙧𝙚𝙫𝙚𝙣𝙩 𝙚𝙦𝙪𝙞𝙥𝙢𝙚𝙣𝙩 𝙢𝙖𝙡𝙛𝙪𝙣𝙘𝙩𝙞𝙤𝙣𝙨 𝙖𝙝𝙚𝙖𝙙 𝙤𝙛 𝙩𝙞𝙢𝙚.”

Watch short snippets from our segment with CEO Alexander Seyf; Chief Technology Officer Alexis Blain; Head of Product Management Alexa Craciunescu; Head of Global Cell & Gene Therapy at ‪@yposkesi‬ John Lee, Jr.; and Tom Whitehead, Co-Founder of ‪@emilywhiteheadfoundation1207‬, which aims to improve #cancer options to treat children.

🎬 𝗗𝗠𝗚 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻𝘀 | ‪@AllianceRegenMed‬